Hidradenitis Suppurativa
Anuradha R. Bhama
Scott R. Steele
Perioperative Considerations
The prevalence of hidradenitis suppurativa (HS) is 0.1%-4% worldwide, with the mean age of onset 20-24 years.
Multiple risk factors are known for HS.
Cigarette smoking and obesity
Dietary triggers including dairy products and highly refined simple carbohydrates
The anal region is the second most commonly involved area after the axilla; ˜30%-50% of patients with HS have perianal lesions as a location of their disease (Fig. 13-1).
A number of comorbid conditions can be present in patients with HS.
Acne
Inflammatory bowel disease
Spondyloarthropathy
Genetic keratin disorders
Squamous cell cancer
Local and small lesions can benefit from medical treatment, but recurrence rates are high.
Antibiotics
Topical (eg, clindamycin)
Oral (eg, tetracycline, clindamycin, rifampin)
Monoclonal antibodies (eg, adalimumab, infliximab)
Indications for surgical treatment
Widespread disease is an indication for radical surgical excision with possible need for reconstruction with a flap.
Acute abscess (incision and drainage [I&D])
Chronic or recurrent HS nonresponsive to medical therapy
Intolerance of medical treatment
Positioning
Positioning will depend on the location and extent of the disease.
Either prone jackknife or lithotomy positions can be utilized (Fig. 13-2).
Positioning may need to allow for harvesting of skin grafts or rotation of flaps.
Changing of positioning for various segments of the operation may be necessary.
Special Equipment
I&D/lay-open technique
Fistula probes
Electrocautery
Hydrogen peroxide
Angiocath on 10 mL syringe
Excision and grafting
Excision
#15 or #10 blade and scalpel
Electrocautery
Forceps
Grafting
Dermatome
Air-powered dermatome (Zimmer)
Electric-powered dermatome
Size of dermatome can be 1, 2, 3, or 4 in wide.
Skin mesher
Two types
With carrier—disposable carrier helps minimize risk of damage to fragile grafts
Without carrier
Different ratios of meshing (1:1, 1:2, 1:3)
Telfa gauze soaked in epinephrine (1:1000 dilution)
Negative-pressure dressing (wound Vac)
Forceps
Suture or staples
Flaps
Standard soft-tissue operating set
Drain
Technique
I&D/lay-open technique
Use fistula probe to identify deeper tracts (Fig. 13-3A and B).
FIGURE 13-3 ▪ A and B. Identifying tracts using fistula probes.Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Get Clinical Tree app for offline access